Table 2.
Comorbidities | No DM | NIDDM | IDDM | p-value: NIDDM vs No DM a | p-value: IDDM vs No DM a | p-value: IDDM vs NIDDM a |
---|---|---|---|---|---|---|
Total patients, n | 6256 | 975 | 447 | |||
COPD, n (%) | 251 (4.0) | 65 (6.7) | 49 (11.0) | < 0.001 | < 0.001 | 0.006 |
CHF, n (%) | 2 (0.0) | 1 (0.1) | 5 (1.1) | 0.314 | < 0.001 | 0.006 |
Hypertension, n (%) | 2878 (46.0) | 795 (81.5) | 377 (84.3) | < 0.001 | < 0.001 | 0.198 |
Dialysis, n (%) | 6 (0.1) | 1 (0.1) | 4 (0.9) | 0.950 | < 0.001 | 0.019 |
Renal failure, n (%) | 0 (0.0) | 2 (0.2) | 1 (0.2) | < 0.001 | < 0.001 | 0.943 |
Steroid use, n (%) | 131 (2.1) | 14 (1.4) | 6 (1.3) | 0.173 | 0.278 | 0.889 |
Bleeding disorder, n (%) | 106 (1.7) | 20 (2.1) | 19 (4.3) | 0.428 | < 0.001 | 0.018 |
Dyspnea, n (%) | 0.010 | < 0.001 | 0.004 | |||
No dyspnea | 5945 (95.0) | 906 (92.9) | 393 (87.9) | |||
Moderate exertion | 285 (4.6) | 66 (6.8) | 49 (11.0) | |||
At rest | 26 (0.4) | 3 (0.3) | 5 (1.1) | |||
Anesthesia type, n (%) | 0.622 | 0.832 | 0.663 | |||
General | 5980 (95.7) | 937 (96.2) | 433 (96.9) | |||
Neuraxial | 7 (0.1) | 0 (0.0) | 0 (0.0) | |||
Regional | 197 (3.2) | 32 (3.3) | 11 (2.5) | |||
MAC | 52 (0.8) | 4 (0.4) | 3 (0.7) |
Pearson's chi-squared test.
DM, diabetes mellitus; NIDDM, non-insulin dependent diabetes mellitus; IDDM, insulin dependent diabetes mellitus; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; MAC, monitored anesthetic care.
Bolding indicates that the p-value is significant, which means that it is less than 0.05.